Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells

By Pino Maria   Billack Blase  

Cutaneous and Ocular Toxicology (formerly Journal of Toxicology - Cutaneous and, Vol. 27, Iss. 3, 2008-09 ,pp. : 161-172

Informa Healthcare

Access to resources Recommend Favorite

Effects of co-administration of butylated hydroxytoluene, butylated hydroxyanisole and flavonoids on the activation of mutagens and drug-metabolizing enzymes in mice

By Sun B.   Fukuhara M.  

Toxicology, Vol. 122, Iss. 1, 1997-09 ,pp. : 61-72

Elsevier

Access to resources Recommend Favorite

Formation of 8-hydroxydeoxyguanosine in calf thymus DNA treated with tert-butylhydroquinone, a major metabolite of butylated hydroxyanisole

By Nagai F.   Okubo T.   Ushiyama K.   Satoh K.   Kano I.  

Toxicology Letters, Vol. 89, Iss. 2, 1996-12 ,pp. : 163-167

Elsevier

Access to resources Recommend Favorite

Modulation of halobenzene-induced hepatotoxicity by DT-diaphorase modulators, butylated hydroxyanisole and dicoumarol: evidence for possible involvement of quinone metabolites in the toxicity of halobenzenes

By Mizutani T.   Miyamoto Y.  

Toxicology Letters, Vol. 105, Iss. 1, 1999-03 ,pp. : 25-30

Elsevier

Access to resources Recommend Favorite

Urinary Pharmacokinetics of 11-Nor-9-carboxy-Δ 9 -tetrahydrocannabinol after Controlled Oral Δ 9 -Tetrahydrocannabinol Administration

By Gustafson Richard A.  

Journal of Analytical Toxicology, Vol. 28, Iss. 3, 2004-04 ,pp. : 160-167

Oxford University Press

Access to resources Recommend Favorite